MetLife (MET)
Market Price (3/15/2026): $67.99 | Market Cap: $44.7 BilSector: Financials | Industry: Life & Health Insurance
MetLife (MET)
Market Price (3/15/2026): $67.99Market Cap: $44.7 BilSector: FinancialsIndustry: Life & Health Insurance
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, Dividend Yield is 3.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 7.0%, FCF Yield is 38% | Weak multi-year price returns2Y Excs Rtn is -31%, 3Y Excs Rtn is -59% | |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -219% | ||
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23%, CFO LTM is 17 Bil, FCF LTM is 17 Bil | ||
| Low stock price volatilityVol 12M is 29% | ||
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Digital & Alternative Assets, AI in Financial Services, and Sustainable Finance. Show more. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, Dividend Yield is 3.4%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 7.0%, FCF Yield is 38% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -219% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 23%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23%, CFO LTM is 17 Bil, FCF LTM is 17 Bil |
| Low stock price volatilityVol 12M is 29% |
| Megatrend and thematic driversMegatrends include Aging Population & Chronic Disease, Digital & Alternative Assets, AI in Financial Services, and Sustainable Finance. Show more. |
| Weak multi-year price returns2Y Excs Rtn is -31%, 3Y Excs Rtn is -59% |
Qualitative Assessment
AI Analysis | Feedback
MetLife (MET) stock has lost about 10% since 11/30/2025 because of the following key factors:
1. Mixed Fourth Quarter 2025 Earnings Report with Revenue Miss and Future Outlook Concerns.
MetLife reported adjusted earnings per share (EPS) of $2.49 for Q4 2025, which exceeded analysts' consensus estimates of $2.34 by $0.15. However, the company's revenue of $23.81 billion fell short of analysts' expectations of $27.21 billion, representing a 12.5% miss. This mixed performance was compounded by analysts anticipating downward adjustments to EPS for 2024, projected to be 3.5% below consensus estimates, and foreseeing an estimated headwind of $300-$325 million to Retirement and Income Solutions (RIS) earnings as interest rate caps roll off, potentially leading to further EPS declines of approximately $0.20 per share.
2. Analyst Price Target Reductions Reflecting Cautious Outlook.
Several Wall Street analysts revised their price targets for MetLife downwards in the period following the earnings report. For example, Morgan Stanley cut its price target from $101 to $93 on March 3, 2026, while maintaining an 'Overweight' rating. TD Cowen also lowered its target from $91 to $88 on March 11, 2026, retaining a 'Buy' rating. Wells Fargo reduced its target from $97 to $93 on February 25, 2026, also maintaining an 'Overweight' stance. These adjustments indicate a more cautious perspective influenced by anticipated challenges in key segments and broader macroeconomic headwinds.
Show more
1. Mixed Fourth Quarter 2025 Earnings Report with Revenue Miss and Future Outlook Concerns.
MetLife reported adjusted earnings per share (EPS) of $2.49 for Q4 2025, which exceeded analysts' consensus estimates of $2.34 by $0.15. However, the company's revenue of $23.81 billion fell short of analysts' expectations of $27.21 billion, representing a 12.5% miss. This mixed performance was compounded by analysts anticipating downward adjustments to EPS for 2024, projected to be 3.5% below consensus estimates, and foreseeing an estimated headwind of $300-$325 million to Retirement and Income Solutions (RIS) earnings as interest rate caps roll off, potentially leading to further EPS declines of approximately $0.20 per share.
2. Analyst Price Target Reductions Reflecting Cautious Outlook.
Several Wall Street analysts revised their price targets for MetLife downwards in the period following the earnings report. For example, Morgan Stanley cut its price target from $101 to $93 on March 3, 2026, while maintaining an 'Overweight' rating. TD Cowen also lowered its target from $91 to $88 on March 11, 2026, retaining a 'Buy' rating. Wells Fargo reduced its target from $97 to $93 on February 25, 2026, also maintaining an 'Overweight' stance. These adjustments indicate a more cautious perspective influenced by anticipated challenges in key segments and broader macroeconomic headwinds.
Show more
Stock Movement Drivers
Fundamental Drivers
The -10.6% change in MET stock from 11/30/2025 to 3/14/2026 was primarily driven by a -17.4% change in the company's Net Income Margin (%).| (LTM values as of) | 11302025 | 3142026 | Change |
|---|---|---|---|
| Stock Price ($) | 76.02 | 67.97 | -10.6% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 70,952 | 75,611 | 6.6% |
| Net Income Margin (%) | 5.4% | 4.5% | -17.4% |
| P/E Multiple | 13.2 | 13.2 | 0.6% |
| Shares Outstanding (Mil) | 665 | 658 | 1.0% |
| Cumulative Contribution | -10.6% |
Market Drivers
11/30/2025 to 3/14/2026| Return | Correlation | |
|---|---|---|
| MET | -10.6% | |
| Market (SPY) | -3.1% | 45.3% |
| Sector (XLF) | -8.3% | 73.7% |
Fundamental Drivers
The -15.3% change in MET stock from 8/31/2025 to 3/14/2026 was primarily driven by a -24.6% change in the company's Net Income Margin (%).| (LTM values as of) | 8312025 | 3142026 | Change |
|---|---|---|---|
| Stock Price ($) | 80.20 | 67.97 | -15.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 72,369 | 75,611 | 4.5% |
| Net Income Margin (%) | 5.9% | 4.5% | -24.6% |
| P/E Multiple | 12.5 | 13.2 | 5.5% |
| Shares Outstanding (Mil) | 671 | 658 | 1.9% |
| Cumulative Contribution | -15.3% |
Market Drivers
8/31/2025 to 3/14/2026| Return | Correlation | |
|---|---|---|
| MET | -15.3% | |
| Market (SPY) | 3.0% | 46.1% |
| Sector (XLF) | -9.1% | 74.6% |
Fundamental Drivers
The -18.8% change in MET stock from 2/28/2025 to 3/14/2026 was primarily driven by a -29.1% change in the company's Net Income Margin (%).| (LTM values as of) | 2282025 | 3142026 | Change |
|---|---|---|---|
| Stock Price ($) | 83.69 | 67.97 | -18.8% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 70,252 | 75,611 | 7.6% |
| Net Income Margin (%) | 6.3% | 4.5% | -29.1% |
| P/E Multiple | 13.1 | 13.2 | 1.0% |
| Shares Outstanding (Mil) | 693 | 658 | 5.3% |
| Cumulative Contribution | -18.8% |
Market Drivers
2/28/2025 to 3/14/2026| Return | Correlation | |
|---|---|---|
| MET | -18.8% | |
| Market (SPY) | 12.4% | 75.0% |
| Sector (XLF) | -5.3% | 85.9% |
Fundamental Drivers
The 4.0% change in MET stock from 2/28/2023 to 3/14/2026 was primarily driven by a 36.5% change in the company's P/E Multiple.| (LTM values as of) | 2282023 | 3142026 | Change |
|---|---|---|---|
| Stock Price ($) | 65.37 | 67.97 | 4.0% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 67,408 | 75,611 | 12.2% |
| Net Income Margin (%) | 7.8% | 4.5% | -43.0% |
| P/E Multiple | 9.7 | 13.2 | 36.5% |
| Shares Outstanding (Mil) | 784 | 658 | 19.1% |
| Cumulative Contribution | 4.0% |
Market Drivers
2/28/2023 to 3/14/2026| Return | Correlation | |
|---|---|---|
| MET | 4.0% | |
| Market (SPY) | 73.4% | 60.1% |
| Sector (XLF) | 43.1% | 80.5% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MET Return | 37% | 19% | -5% | 28% | -1% | -11% | 75% |
| Peers Return | 45% | 1% | 6% | 17% | 19% | -10% | 94% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | -1% | 80% |
Monthly Win Rates [3] | |||||||
| MET Win Rate | 67% | 67% | 58% | 67% | 58% | 33% | |
| Peers Win Rate | 70% | 53% | 55% | 58% | 65% | 33% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 33% | |
Max Drawdowns [4] | |||||||
| MET Max Drawdown | -2% | -6% | -31% | -1% | -16% | -11% | |
| Peers Max Drawdown | -4% | -22% | -23% | -4% | -9% | -12% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -2% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: PRU, AIG, AFL, LNC, PFG. See MET Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/13/2026 (YTD)
How Low Can It Go
| Event | MET | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -36.2% | -25.4% |
| % Gain to Breakeven | 56.7% | 34.1% |
| Time to Breakeven | 472 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -55.2% | -33.9% |
| % Gain to Breakeven | 123.0% | 51.3% |
| Time to Breakeven | 319 days | 148 days |
| 2018 Correction | ||
| % Loss | -31.4% | -19.8% |
| % Gain to Breakeven | 45.7% | 24.7% |
| Time to Breakeven | 785 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -82.9% | -56.8% |
| % Gain to Breakeven | 485.7% | 131.3% |
| Time to Breakeven | 4,437 days | 1,480 days |
Compare to PRU, AIG, AFL, LNC, PFG
In The Past
MetLife's stock fell -36.2% during the 2022 Inflation Shock from a high on 11/25/2022. A -36.2% loss requires a 56.7% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About MetLife (MET)
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
AI Analysis | Feedback
Think of MetLife as a diversified insurance and financial services giant, similar to Prudential or AIG.
AI Analysis | Feedback
MetLife (MET) provides a diverse range of financial products and services, primarily categorized as follows:
- Life Insurance: Offers individual, group, universal, and variable life policies designed to provide financial protection to beneficiaries.
- Health & Specialty Insurance: Provides a variety of coverages including dental, vision, short- and long-term disability, pet insurance, and long-term care.
- Annuities: Sells fixed, indexed-linked, variable, and institutional income annuities for retirement savings and income generation.
- Employee Benefits Solutions: Delivers services to employers such as prepaid legal plans, administrative services-only arrangements, and funding for postretirement and executive benefit programs.
- Pension Risk Transfers & Structured Settlements: Manages financial risks for defined benefit pension plans and provides guaranteed payment streams for legal settlements.
- Investment & Savings Products: Offers general and separate account products, funding agreements, capital markets investment products, and regular savings products.
AI Analysis | Feedback
MetLife (NYSE: MET) serves a diverse range of customers across its various segments, encompassing both business-to-business (B2B) and business-to-consumer (B2C) operations globally. Due to the vast number of corporate and individual clients, identifying specific "major customer companies" by name is not applicable or publicly disclosed for a financial services provider of this nature. Instead, MetLife's major customers can be most accurately identified by the following categories:
-
Employers and Corporate Clients: This category includes various businesses and organizations of all sizes that purchase MetLife's group insurance products and benefit programs for their employees. These offerings encompass group life, dental, short-and long-term disability, vision, accident & health coverages, and prepaid legal plans. MetLife also provides administrative services-only (ASO) arrangements and solutions for financing nonqualified benefit programs for executives (e.g., company, bank, or trust-owned life insurance).
-
Institutional Clients: This segment consists of pension funds, other financial institutions, and large corporations that utilize MetLife's specialized services. These include pension risk transfers, institutional income annuities, structured settlements, and various capital markets investment products.
-
Individual Consumers: MetLife serves a vast number of individual consumers directly. These customers purchase a wide range of personal insurance and financial products such as whole life, term life, endowments, universal and variable life insurance, individual disability insurance, pet insurance, fixed, indexed-linked, and variable annuities, regular savings products, and protection against long-term healthcare services.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
Insurtech companies leveraging advanced technologies (such as artificial intelligence and big data analytics) and direct-to-consumer digital platforms pose a clear emerging threat. These companies are streamlining the insurance purchasing process, offering personalized products, providing instant underwriting decisions, and reducing administrative overhead, creating a more convenient and often lower-cost experience for customers. This directly threatens MetLife's traditional distribution channels (agents, brokers), its reliance on legacy IT infrastructure, and its ability to compete on speed, personalization, and cost across segments such as individual life insurance, pet insurance, and certain employee benefits.
AI Analysis | Feedback
nullAI Analysis | Feedback
nullAI Analysis | Feedback
null
Latest Trefis Analyses
Trade Ideas
Select ideas related to MET.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 02282026 | NDAQ | Nasdaq | Insider | Insider Buys 45DStrong Insider BuyingCompanies with multiple insider buys in the last 45 days | 0.0% | 0.0% | 0.0% |
| 02272026 | JEF | Jefferies Financial | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | 0.0% | 0.0% | 0.0% |
| 02272026 | PAYO | Payoneer Global | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02272026 | FOUR | Shift4 Payments | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 0.0% | 0.0% | 0.0% |
| 02202026 | COIN | Coinbase Global | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | 2.6% | 2.6% | -6.5% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 81.28 |
| Mkt Cap | 36.8 |
| Rev LTM | 22,558 |
| Op Inc LTM | - |
| FCF LTM | 3,876 |
| FCF 3Y Avg | 4,249 |
| CFO LTM | 3,925 |
| CFO 3Y Avg | 4,294 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | -2.5% |
| Rev Chg 3Y Avg | 0.8% |
| Rev Chg Q | -3.0% |
| QoQ Delta Rev Chg LTM | -0.9% |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | 13.5% |
| CFO/Rev 3Y Avg | 14.9% |
| FCF/Rev LTM | 13.5% |
| FCF/Rev 3Y Avg | 14.9% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 36.8 |
| P/S | 0.9 |
| P/EBIT | 9.7 |
| P/E | 13.3 |
| P/CFO | 4.6 |
| Total Yield | 10.4% |
| Dividend Yield | 3.5% |
| FCF Yield 3Y Avg | 13.5% |
| D/E | 0.3 |
| Net D/E | -1.5 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -8.3% |
| 3M Rtn | -13.1% |
| 6M Rtn | -6.7% |
| 12M Rtn | -5.4% |
| 3Y Rtn | 54.2% |
| 1M Excs Rtn | -6.7% |
| 3M Excs Rtn | -8.2% |
| 6M Excs Rtn | -9.4% |
| 12M Excs Rtn | -23.5% |
| 3Y Excs Rtn | -44.9% |
Segment Financials
Revenue by Segment| $ Mil | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Group Benefits | 26,122 | 25,230 | 24,402 | ||
| Retirement and Income Solutions (RIS) | 17,076 | 16,635 | 20,518 | ||
| Asia | 11,415 | 10,926 | 11,255 | 13,360 | |
| Latin America | 7,586 | 7,371 | 6,031 | 5,030 | |
| Revenues attributed to business activities within Corporate & Other | 7,357 | ||||
| Europe, the Middle East, and Africa (EMEA) | 2,770 | 2,543 | 2,441 | 2,928 | |
| Unit-linked investment income | 1,091 | ||||
| MetLife Investment Management, the Company’s institutional asset management business (MIM) | 725 | ||||
| Other | 224 | 791 | |||
| Reinsurance activity | 31 | ||||
| Investment hedge adjustments | -604 | -1,012 | |||
| Net investment gains (losses) | -1,184 | -2,824 | |||
| Net derivative gains (losses) | -1,623 | -2,140 | |||
| MetLife Holdings | 8,202 | 9,037 | 11,141 | ||
| Unit-linked investment income and Reinsurance adjustments | 1,183 | ||||
| Corporate & Other | 655 | 701 | |||
| Reinsurance adjustments | -5,569 | 836 | |||
| United States (U.S.) | 37,084 | ||||
| Total | 70,986 | 66,905 | 68,770 | 71,080 |
Price Behavior
Price Behavior
| Market Price | $67.97 | |
| Market Cap ($ Bil) | 45.2 | |
| First Trading Date | 04/05/2000 | |
| Distance from 52W High | -17.1% | |
| 50 Days | 200 Days | |
| DMA Price | $76.13 | $77.37 |
| DMA Trend | indeterminate | down |
| Distance from DMA | -10.7% | -12.1% |
| 3M | 1YR | |
| Volatility | 26.4% | 28.8% |
| Downside Capture | 140.62 | 129.99 |
| Upside Capture | 49.03 | 92.31 |
| Correlation (SPY) | 43.3% | 74.5% |
MET Betas & Captures as of 2/28/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 1.57 | 1.31 | 1.14 | 0.99 | 1.16 | 1.05 |
| Up Beta | 0.34 | 0.92 | 0.52 | 0.61 | 1.02 | 0.96 |
| Down Beta | 3.70 | 1.87 | 1.48 | 1.16 | 1.38 | 1.33 |
| Up Capture | 105% | 75% | 97% | 72% | 94% | 67% |
| Bmk +ve Days | 9 | 20 | 31 | 70 | 142 | 431 |
| Stock +ve Days | 12 | 20 | 28 | 61 | 134 | 409 |
| Down Capture | 160% | 155% | 132% | 121% | 117% | 102% |
| Bmk -ve Days | 12 | 21 | 30 | 54 | 109 | 320 |
| Stock -ve Days | 9 | 21 | 33 | 63 | 117 | 340 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MET | |
|---|---|---|---|---|
| MET | -11.6% | 29.0% | -0.42 | - |
| Sector ETF (XLF) | 3.6% | 19.3% | 0.06 | 85.5% |
| Equity (SPY) | 19.6% | 18.9% | 0.81 | 74.8% |
| Gold (GLD) | 71.9% | 26.3% | 2.05 | -2.6% |
| Commodities (DBC) | 19.3% | 17.3% | 0.89 | 25.0% |
| Real Estate (VNQ) | 6.2% | 16.3% | 0.19 | 61.0% |
| Bitcoin (BTCUSD) | -15.3% | 44.2% | -0.25 | 27.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MET | |
|---|---|---|---|---|
| MET | 5.6% | 25.7% | 0.21 | - |
| Sector ETF (XLF) | 9.3% | 18.7% | 0.38 | 82.4% |
| Equity (SPY) | 13.1% | 17.0% | 0.61 | 60.8% |
| Gold (GLD) | 24.1% | 17.3% | 1.14 | -2.4% |
| Commodities (DBC) | 11.2% | 19.0% | 0.47 | 19.7% |
| Real Estate (VNQ) | 4.8% | 18.8% | 0.16 | 48.3% |
| Bitcoin (BTCUSD) | 6.3% | 56.7% | 0.33 | 19.7% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with MET | |
|---|---|---|---|---|
| MET | 9.7% | 30.5% | 0.37 | - |
| Sector ETF (XLF) | 12.5% | 22.2% | 0.52 | 86.0% |
| Equity (SPY) | 14.5% | 17.9% | 0.70 | 69.2% |
| Gold (GLD) | 14.4% | 15.6% | 0.77 | -7.3% |
| Commodities (DBC) | 8.6% | 17.6% | 0.40 | 28.4% |
| Real Estate (VNQ) | 5.6% | 20.7% | 0.23 | 53.9% |
| Bitcoin (BTCUSD) | 67.4% | 66.8% | 1.07 | 16.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 2/4/2026 | -3.4% | 1.1% | -7.9% |
| 11/5/2025 | -3.4% | 1.9% | -0.8% |
| 8/6/2025 | -2.8% | 1.9% | 4.7% |
| 4/30/2025 | 0.5% | 2.6% | 5.0% |
| 2/5/2025 | -1.6% | -2.7% | -3.2% |
| 10/30/2024 | -5.7% | 0.8% | 6.8% |
| 7/31/2024 | -1.4% | -9.8% | 0.7% |
| 5/1/2024 | -2.3% | 0.5% | 1.5% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 9 | 14 | 16 |
| # Negative | 15 | 10 | 8 |
| Median Positive | 2.4% | 2.2% | 3.7% |
| Median Negative | -2.3% | -2.6% | -7.0% |
| Max Positive | 6.1% | 16.7% | 25.3% |
| Max Negative | -7.8% | -10.9% | -9.2% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 12/31/2025 | 02/19/2026 | 10-K |
| 09/30/2025 | 11/07/2025 | 10-Q |
| 06/30/2025 | 08/07/2025 | 10-Q |
| 03/31/2025 | 05/01/2025 | 10-Q |
| 12/31/2024 | 02/21/2025 | 10-K |
| 09/30/2024 | 11/01/2024 | 10-Q |
| 06/30/2024 | 08/01/2024 | 10-Q |
| 03/31/2024 | 05/02/2024 | 10-Q |
| 12/31/2023 | 02/16/2024 | 10-K |
| 09/30/2023 | 11/02/2023 | 10-Q |
| 06/30/2023 | 08/04/2023 | 10-Q |
| 03/31/2023 | 05/04/2023 | 10-Q |
| 12/31/2022 | 02/23/2023 | 10-K |
| 09/30/2022 | 11/03/2022 | 10-Q |
| 06/30/2022 | 08/04/2022 | 10-Q |
| 03/31/2022 | 05/05/2022 | 10-Q |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pappas, Bill | EVP, Global Tech. & Ops. | Direct | Sell | 5132025 | 80.49 | 26,000 | 2,092,683 | 5,372,078 | Form |
Industry Resources
| Financials Resources |
| Federal Reserve Economic Data |
| Federal Reserve |
| FDIC Data |
| American Banker |
| The Banker |
| Banking Technology |
| Life & Health Insurance Resources |
| Insurance Business America |
| A.M. Best |
| National Underwriter |
| Insurance News |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.